Drug & intervention

pentostatin

RxCUI 8011

Clinical trials2

Recruiting0

Related conditions4

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Background context

Pentostatin

Pentostatin (or 2′-deoxycoformycin, trade name Nipent, manufactured by SuperGen) is an anticancer chemotherapeutic drug.

Read on Wikipedia ↗ Wikidata Q425470 ↗

Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

2 shown

SS1P and Pentostatin Plus Cyclophosphamide for MesotheliomaNCT01362790 · 2011-05-11

Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in ChildrenNCT00144430 · 2004-01-01

Conditions being studied

Adenocarcinoma of Lung1 Graft vs Host Disease1 Mesothelioma1 Pancreatic Neoplasms1

Research locations

Ann ArborMichigan, United States1 AtlantaGeorgia, United States1 BaltimoreMaryland, United States1 BethesdaMaryland, United States1 ChicagoIllinois, United States1 ClevelandOhio, United States1 ColumbusOhio, United States1 DallasTexas, United States1 Fort WorthTexas, United States1 Grand RapidsMichigan, United States1 HackensackNew Jersey, United States1 HersheyPennsylvania, United States1

Leading sponsors

Ann & Robert H Lurie Children's Hospital of Chicago1 National Cancer Institute (NCI)1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.